Round the Wire: ASH 2021

Welcome to Docwire News’ expert roundtable series on research presented at ASH 2021. Moderating the series is Saad Usmani, MD. He is accompanied by a panel of experts, including Sham Mailankody, MBBS, Malin Hultcrantz, MD, PhD, Urvi A. Shah, MD, and Cesar Rodriguez, MD. Together, they cover topics such as smoldering multiple myeloma, newly diagnosed multiple myeloma, and relapsed/refractory multiple myeloma.

Relapsed/Refractory Multiple Myeloma

video

Translating Data from ASH 2021: The COMPASS Study

In the final part of the Multiple Myeloma Today roundtable series on Translating Data from research presented at the 2021 Annual Meeting and Exposition...
video

Translating Data from ASH 2021: Post-BCMA Therapy

In the third part of Multiple Myeloma Today’s roundtable series on Translating Data from research presented at the American Society of Hematology's (ASH) 2021...
video

Relapsed/Refractory Multiple Myeloma: BCMA Targeted Bispecifics

In part 2 of Docwire News’ roundtable series discussing Relapsed/Refractory Multiple Myeloma, moderator Dr. Saad Usmani and Dr. Cesar Rodriguez discuss research presented at...
video

Relapsed Multiple Myeloma: Iberdomide and CC-480 CELMoDs

In the final part of Docwire News’ roundtable series discussing Relapsed/Refractory Multiple Myeloma, moderator Dr. Saad Usmani and Dr. Urvi Shah discuss data presented...
video

Relapsed Multiple Myeloma: Cellular Therapy

In Docwire News’ roundtable series discussing research presented at ASH 2021, moderator Dr. Saad Usmani is joined by Dr. Sham Mailankody to discuss cellular...

The Panel

Saad Usmani

Saad Usmani

MD, MBA, FACP

Memorial Sloan Kettering

Sham Mailankody

Sham Mailankody

MBBS

Memorial Sloan Kettering

Malin Hultcrantz, MD PhD

Malin Hultcrantz

MD, PhD

Memorial Sloan Kettering

Urvi A. Shah, MD

Urvi A. Shah

MD

Memorial Sloan Kettering

dr. Cesar Rodriguez

Cesar Rodriguez

MD

Mount Sinai

Advertisement
Advertisement